The post-hoc analysis revealed highly significant differences in pTau181 levels between AD and CBS-Aβ(–) (p < 0.001) as well as AD and HC (p = 0.000), with a moderate significance observed between CBS-Aβ(–) and HC (p = 0.004) (Table 6). This evidence concerns the gene CBS and Alzheimer disease.